Financhill
Back

Biodexa Pharmaceuticals Plc Quote, Financials, Valuation and Earnings

What's Nvidia doing next??

Click here now to learn more about Nvidia's next AI move.
Sell
41

BDRX
Biodexa Pharmaceuticals Plc

Last Price:
0.89
Seasonality Move:
-1.3%

7 Day Trial

ALL ACCESS PASS

$ 7

Buy a stock when it crosses this line on the chart

Here's the line to follow.

Biodexa Pharmaceuticals Plc Price Quote

$0.89
+0.00 (+-0.77%)
(Updated: July 4, 2024 at 5:39 AM ET)

Biodexa Pharmaceuticals Plc Key Stats

Sell
41
Biodexa Pharmaceuticals Plc (BDRX) is a Sell

Day range:
$0.86 - $0.91
52-week range:
$0.67 - $9.74
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.79
P/B ratio:
1.35%

Volume:
147K
Avg. volume:
4.9M
1-year change:
-83.03%
Market cap:
$8.1M
Revenue:
$474.1K
EPS:
$-402

How Much Does Biodexa Pharmaceuticals Plc Make?

Is Biodexa Pharmaceuticals Plc Growing As A Company?

Data Unavailable

Biodexa Pharmaceuticals Plc Stock Price Performance

What Is Biodexa Pharmaceuticals Plc 52-Week High & Low?

Biodexa Pharmaceuticals Plc Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Biodexa Pharmaceuticals Plc?

Is Biodexa Pharmaceuticals Plc Cash Flow Positive?

  • What Is BDRX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$8.5M
  • What Is Biodexa Pharmaceuticals Plc’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $12.8M
  • What Is Biodexa Pharmaceuticals Plc’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$328.9K

Biodexa Pharmaceuticals Plc Return On Invested Capital

  • Is Management Doing A Good Job?
    BDRX return on invested capital is -160.77%
  • What Is Biodexa Pharmaceuticals Plc Return On Assets?
    ROA measures how assets are converting to revenues and is -87.8%
  • What Is BDRX Return On Equity?
    ROE is a measure of profitability and is -160.77%

Biodexa Pharmaceuticals Plc Earnings Date & Stock Price

Biodexa Pharmaceuticals Plc Competitors

Biodexa Pharmaceuticals Plc Dividend Yield

Data Unavailable

Biodexa Pharmaceuticals Plc Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 8.02
Upside from Last Price: 801.19%

Major Shareholders

  • How many BDRX shares are owned by institutional investors?
    46.2K BDRX shares are owned by institutional investors
  • How many BDRX shares are owned by insiders?
    1.3M BDRX shares are owned by insiders